HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.

AbstractBACKGROUND:
Chronic antigenic stimulation might have a role in the pathogenesis of monoclonal gammopathy of unknown significance (MGUS) and multiple myeloma. The aim of this study was to search for factors underlying the autoimmunogenicity of paratarg-7, a frequent antigenic target of paraproteins in MGUS and multiple myeloma.
METHODS:
Between January, 2005, and February, 2009, serum and peripheral blood cells were obtained from consecutive patients with MGUS or multiple myeloma and healthy blood donors, and paratarg-7 was analysed by DNA sequencing, SDS-PAGE, isoelectric focusing, and western blotting.
FINDINGS:
Mutations or polymorphisms of paratarg-7 were not noted, but hyperphosphorylation was detected in 35 (13.9%) of 252 patients with MGUS or multiple myeloma, all of whom had an anti-paratarg-7-specific paraprotein. Analysis of eight families showed that hyperphosphorylated paratarg-7 is inherited in a dominant fashion, and that carriers of hyperphosphorylated paratarg-7 have an increased risk of developing MGUS and multiple myeloma (odds ratio [OR] 7.9, 95% CI 2.8-22.6; p=0.0001).
INTERPRETATION:
Familial MGUS and multiple myeloma were associated with a dominant inheritance of hyperphosphorylated paratarg-7, enabling family members at increased risk for MGUS or multiple myeloma to be identified. That only patients with MGUS or multiple myeloma who are carriers of hyperphosphorylated paratarg-7 had a paratarg-7-specific paraprotein suggests that the hyperphosphorylation of paratarg-7 induces auto-immunity and is involved in the pathogenesis of MGUS and multiple myeloma; for example, by chronic antigenic stimulation.
FUNDING:
Förderverein Krebsforschung Saar-Pfalz-Mosel e.V. (eingetragener Verein: officially registered charity) and HOMFOR (the research programme of the Saarland University Faculty of Medicine).
AuthorsSandra Grass, Klaus-Dieter Preuss, Manfred Ahlgrimm, Natalie Fadle, Evi Regitz, Claudia Pfoehler, Niels Murawski, Michael Pfreundschuh
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 10 Issue 10 Pg. 950-6 (Oct 2009) ISSN: 1474-5488 [Electronic] England
PMID19767238 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Blood Proteins
  • Membrane Proteins
  • Paraproteins
  • STOML2 protein, human
Topics
  • Adult
  • Aged
  • Blood Proteins (physiology)
  • Case-Control Studies
  • Child
  • Female
  • Genes, Dominant
  • Humans
  • Male
  • Membrane Proteins (physiology)
  • Middle Aged
  • Monoclonal Gammopathy of Undetermined Significance (genetics, metabolism, pathology)
  • Multiple Myeloma (genetics, metabolism, pathology)
  • Paraproteins (physiology)
  • Pedigree
  • Phosphorylation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: